Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.280
-0.030 (-1.29%)
Apr 23, 2026, 12:04 PM EDT - Market open
Neumora Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$7.50
Upside
+228.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +514.01% | Mar 31, 2026 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +250.86% | Mar 31, 2026 |
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Feb 17, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $8 | Buy | Initiates | $8 | +250.86% | Jan 12, 2026 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $4 → $7 | Hold → Buy | Upgrades | $4 → $7 | +207.00% | Dec 1, 2025 |
| Stifel | Stifel | Hold Maintains $2 → $3 | Hold | Maintains | $2 → $3 | +31.57% | Nov 17, 2025 |
| Needham | Needham | Strong Buy Maintains $6 → $8 | Strong Buy | Maintains | $6 → $8 | +250.86% | Oct 28, 2025 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +514.01% | Oct 27, 2025 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Sep 16, 2025 |
| Mizuho | Mizuho | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +119.29% | Jul 16, 2025 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +119.29% | May 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +119.29% | Apr 10, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $7 → $1 | Strong Buy → Sell | Downgrades | $7 → $1 | -56.14% | Apr 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 10, 2025 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $6 → $2 | Strong Buy → Hold | Downgrades | $6 → $2 | -12.28% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +689.44% | Mar 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.